Lionel Hutz on Liquidia's patent battle $LQDA (podcast #144)
www.yetanothervalueblog.com
Lionel Hutz discusses his thesis for Liquidia (LQDA) and why the thinks they are likely to win their patent battle against United Therapeutics (UTHR). This episode is sponsored by Visible Alpha. While traditional consensus providers offer limited line items and forecast periods, Visible Alpha fills the gap by creating the deepest consensus data in the market, with more and higher quality sources and longer-term forecast horizons.
Lionel Hutz on Liquidia's patent battle $LQDA (podcast #144)
Lionel Hutz on Liquidia's patent battle $LQDA…
Lionel Hutz on Liquidia's patent battle $LQDA (podcast #144)
Lionel Hutz discusses his thesis for Liquidia (LQDA) and why the thinks they are likely to win their patent battle against United Therapeutics (UTHR). This episode is sponsored by Visible Alpha. While traditional consensus providers offer limited line items and forecast periods, Visible Alpha fills the gap by creating the deepest consensus data in the market, with more and higher quality sources and longer-term forecast horizons.